(S1 (S (S (NP (NN p15INK4B)) (VP (VBZ is) (NP (NP (DT a) (JJ potential) (NN effector)) (PP (IN of) (NP (JJ TGF-beta-induced) (NN cell) (NN cycle) (NN arrest)))))) (. .)))
(S1 (S (S (NP (NP (VBG Transforming) (NN growth) (NN factor-beta)) (PRN (-LRB- -LRB-) (NP (NN TGF-beta)) (-RRB- -RRB-))) (VP (VBZ inhibits) (NP (NN cell) (NN proliferation)) (PP (IN by) (S (VP (VBG inducing) (NP (DT a) (NN G1-phase) (NN cell) (NN cycle) (NN arrest))))))) (. .)))
(S1 (S (S (NP (NP (JJ Normal) (NN progression)) (PP (IN through) (NP (NN G1)))) (VP (VBZ is) (VP (VBN promoted) (PP (IN by) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (DT the) (JJ cyclin-dependent) (NN protein) (NNS kinases)) (NP (NP (NP (NN CDK4)) (CC and) (NP (NN CDK6))) (PRN (-LRB- -LRB-) (NP (NN ref.) (CD 2)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN inhibited) (PP (IN by) (NP (DT the) (NN protein) (NN p16INK4)))))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN isolated) (NP (NP (DT a) (JJ new) (NN member)) (PP (IN of) (NP (DT the) (NN p16INK4) (NN family))) (, ,) (SBAR (WHNP (WDT p15INK4B.)) (S (NP (NN p15) (NN expression)) (VP (VBZ is) (VP (VBN induced) (NP (RB approximately) (RB 30-fold)) (PP (IN in) (NP (JJ human) (NNS keratinocytes))) (PP (IN by) (NP (NP (NN treatment)) (PP (IN with) (NP (NN TGF-beta))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN p15)) (VP (MD may) (VP (VB act) (PP (IN as) (NP (NP (DT an) (NN effector)) (PP (IN of) (NP (JJ TGF-beta-mediated) (NN cell) (NN cycle) (NN arrest))))))))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN gene)) (VP (VBG encoding) (NP (NN p15)))) (VP (VBZ is) (ADJP (JJ located) (PP (IN on) (NP (NN chromosome) (CD 9) (ADJP (JJ adjacent) (PP (TO to) (NP (NP (DT the) (NN p16) (NN gene)) (PP (IN at) (NP (NP (DT a) (JJ frequent) (NN site)) (PP (IN of) (NP (NP (JJ chromosomal) (NN abnormality)) (PP (IN in) (NP (NP (JJ human) (NNS tumours)) (PRN (-LRB- -LRB-) (NP (NN 9p21)) (-RRB- -RRB-)))))))))))))))) (. .)))
